MO-0137 A basis for combining atovaquone-mediated hypoxia alleviation with immunotherapy plus radiotherapy. (May 2022) - Rodriguez-Berriguete, G.; Puliyadi, R.; Prevo, R.; Pugh, C.W.; Higgins, G.S.